Cihan Cetin

Cihan Cetin

Auto-generated profile, based on publicly available information

Cihan Cetin

Department of Obstetrics and Gynecology, Faculty of Medicine, Bahcesehir University, Istanbul 34353, Türkiye

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 June 2015 in The Journal of Maternal-Fetal & Neonatal Medicine
Verified
Journal Article
Closed access
PDF file
CCCihan Cetin
Cihan Cetin
SBSelim Buyukkurt
Selim Buyukkurt
GSGulsah Seydaoglu
Gulsah Seydaoglu
BKBekir Kahveci
Bekir Kahveci
CSCenk Soysal
Cenk Soysal
FOFatma Tuncay Ozgunen
Fatma Tuncay Ozgunen
Objective: To compare the safety and efficacy of two misoprostol regimens for mid-trimester pregnancy terminations. Methods: Retrospective analysis of 263 cases of pregnancy terminations with misoprostol between 12 and 24 weeks was performed. Group 1 (total 129 patients) consisted of patients who were given 200 mcg vaginal misoprostol every 4 h until the abortion, whereas Group 2 patients (total 134 patients) were given misoprostol as in International Federation of Gynecology and Obstetrics’s (FIGO) 2012 recommendation. In case of a previous cesarean section doses were halved in both groups. Primary outcomes of the study were the time to abortion and the total drug dose used. Secondary outcome was the rate of complications. Results: Total dose and time to abortion did not differ between the groups. As for complications, one patient (%0.8) in group 1 developed HELLP syndrome and had hysterotomy. One patient (%0.8) in group 2 had uterine rupture and had total hysterectomy. Two patients in both groups considered failure of induction and terminated with surgery (hysterotomy). Groups did not show difference in induction failure rates. Conclusions: We respect the presence of dose recommendation stated by the FIGO and found similar results with our recent protocol. Other misoprostol regimens used worldwide should also be compared with this guideline in order to improve its efficacy.

21 June 2020 in Clinical Case Reports
Verified
Journal Article
Open access
PDF file
ABAtıl Bışgın
Atıl Bışgın
IBIbrahim Boga
Ibrahim Boga
CCCihan Cetin
Cihan Cetin
SBSELIM BUYUKKURT
SELIM BUYUKKURT
The lack of awareness of patient risk factors, failure to obtain adequate family history, was discussed by clinical experience in prenatal testing of hypophosphatasia with a novel variant in the ALPL gene identified in the index case of the family.

10 March 2025 in Journal of Turkish Society of Obstetric and Gynecology
Verified
Journal Article
Open access
SDSuleyman Cansun Demir
Suleyman Cansun Demir
IPİbrahim Polat
İbrahim Polat
DŞDilek Şahin
Dilek Şahin
AGAli Gedikbaşı
Ali Gedikbaşı
CÇCihan Çetin
Cihan Çetin
ATAtakan Tanaçan
Atakan Tanaçan
Although there are several guidelines in the literature on "recurrent abortion", there is no comprehensive guideline on "threatened abortion". The overall purpose of this guideline is to provide healthcare providers with the best available evidence for examination and treatment of pregnant women with threatened abortion. The scope of the guideline and the first version of the questions were prepared by the Perinatology and High Risk Pregnancies Association (PERİDER) guideline development group in January 2024. Meetings were held to discuss key questions and redefine them. A final list of 8 key questions was created. Keywords were defined for each question and ranked in order of importance and used in searches for all English-language publications in PubMed/Medline and Cochrane libraries. These databases were thoroughly scanned for publications that were published until February 1, 2024. Literature reviews were conducted as an iterative process. In the first step, systematic reviews and meta-analyses were collected. If no results were found, the research was expanded to randomized controlled trials and then to cohort studies and case reports, following the hierarchy of evidence levels. This guideline was presented to the board of directors of the Turkish Gynecology and Obstetrics Society (TJOD). With their suggestions, guideline was finalized, and it was decided to be published as a joint guideline of PERİDER-TJOD. This guideline provides an overview of threatened abortion and the recommended treatments. In addition, by recognizing the deficiencies in the literature, suggestions were made regarding research that could help clinicians' decisions in the future.

30 September 2022 in Cukurova Medical Journal
Verified
Journal Article
Open access
PDF file
BÖBaran Özdemi̇r
Baran Özdemi̇r
ÇAÇağrı Arioğlu Aydin
Çağrı Arioğlu Aydin
CÇCihan Çeti̇n
Cihan Çeti̇n
Himen varyasyonları değişik şekil ve boyutlarda olup kadınlar tarafından genellikle ergenliğe giriş ile fark edilirler. Bu olguda septat himen’e sahip olduğu daha önceden fark edilmemesi sebebiyle cinsel ilişkiye girememe şikâyeti ile başvuran 23 yaşındaki kadın hasta anlatılacaktır. Bu olgu sunumunun amacı nadir görülen bu himen varyasyonuna ve cinsel disfonksiyon şikâyeti ile gelen yetişkin kadın hastaların ayırıcı tanısının yapılmasına dikkat çekmektir.

9 June 2026
Verified
Book Chapter
Closed access
CÇCihan Çetin
Cihan Çetin

24 July 2023 in Hippocrates Medical Journal
Verified
Journal Article
Closed access
ÖDÖzlem Dülger
Özlem Dülger
CÇCihan Çeti̇n
Cihan Çeti̇n
UOUsame Omer Osmanoglu
Usame Omer Osmanoglu
Objective: The aim of this study was to evaluate whether various antenatal factors affect placental weight in term pregnant women who gave birth vaginally. Materials and Methods: This observational study was conducted between January and August 2022 in Karaman Training and Research Hospital. Six hundred and thirty parturients after thirtyseventh gestational week with vaginal delivery were enrolled to this study. The maternal age, parity, body mass index, chronic diseases, and placental weight, weight, length and gender of he newborns were documented. Primary outcome of this study was to evaluate the factors such as age, body mass index, parity, anemia and chronic disesase of mothers and weight of the newborns that may affect placental mass. Assessment of the influence of gender as well as tobacco usage during pregnancy was a secondary outcome of this study. Linear regression analyses with Enter methos was applied while evaluating the factors affecting placental weight. Results: As we evaluated the findings of the study, we found that birth weight and parity had a statistically significant influence on placental weight (p>0,001 and p=0,024 ,respectively). In primipar pregnants , the average weight of the placenta was 580 grams, whereas it was 600 grams in multiparas (p=0,008). Only gestational diabetes was shown to have a significant effect on placental weight when 13 disease categories were investigated (p=0,024).Body mass index of mothers , maternal anemia with hemoglobin level ≤11 gr/dL and smoking habitus had no effect on placental weight. Conclusion: The results of this study support , parity , birthweight of the newborn and gestational diabetes mellitus are critical factors affecting placental weight.